Search - tctmd.com

Displaying 661 - 680 of 704

Sort: Relevancy | Date

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Primed Mesenchymal Stem Cells May Improve Heart Function

Caitlin E. Cox

April 12, 2013

News Daily News

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

Caitlin E. Cox

January 30, 2013

News Daily News

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

Yael L. Maxwell

January 09, 2013

News Daily News

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

L.A. McKeown

November 18, 2012

News Daily News

Frailty Score Predicts 1-Year Mortality But Not Procedural Complications in TAVR

September 18, 2012

News Daily News

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Caitlin E. Cox

August 16, 2012

News Daily News

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

August 14, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

Leah Lawrence

April 20, 2012

News Daily News

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

Caitlin E. Cox

April 16, 2012

News Daily News

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

Caitlin E. Cox

April 12, 2012

News Daily News

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Jason Kahn

April 03, 2012

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Daily News

Right Coronary CTO Forecasts Mortality After Left Main PCI

Leah Lawrence

March 06, 2012

News Daily News

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Jason Kahn

October 31, 2011

News Daily News

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Yael L. Maxwell

October 11, 2011

Advertisement

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Primed Mesenchymal Stem Cells May Improve Heart Function

PROTECT AF: Longer Follow-up Provides Clarity on Watchman vs. Warfarin for A-fib

CABG More Cost-Effective in Patients with Diabetes, Multivessel Disease Over Long Term

High Dose Atorvastatin May Prevent Contrast-Induced Kidney Injury in Elective PCI

Frailty Score Predicts 1-Year Mortality But Not Procedural Complications in TAVR

Meta-analysis: DES Acceptable but Not Trouble-Free for Left Main Disease

Reversible Anticoagulation Shows Promise for ACS Patients Undergoing Catheterization

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

Watchman Works Just as Well Without Warfarin-Protected Transition

Incomplete Revascularization Puts Diabetics at Increased Risk of Long-term Events

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

JAMA Letters Continue Debate Over Genotype, Clopidogrel Response

NY Registry Shows Improved Outcomes with PCI vs. Medical Therapy in Stable Patients

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Right Coronary CTO Forecasts Mortality After Left Main PCI

Small Trial Shows Promise of Cell Therapy in Critical Limb Ischemia

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content